New User:

Forgot your password?

Stock Market & Financial Investment News

Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
October 1, 2015
12:56 EDTCLXClorox sees growing net sales 3%-5% annually through 2020
Subscribe for More Information
05:30 EDTHLFStocks with implied volatility above IV index mean; P HLF
Subscribe for More Information
September 30, 2015
13:11 EDTCLXClorox volatility flat into investor meeting
Clorox October call option implied volatility is at 23, November is at 20; compared to its 52-week range of 12 to 25, suggesting non-directional price movement into a company hosted an investor day on October 1.
08:08 EDTSONSBroadSoft can be a 'significantly larger' company, says Jefferies
Subscribe for More Information
06:58 EDTORCLOracle to furlough workers during holiday week, BI reports
Oracle has decided to close down during the holiday week between Christmas and New Year's, mandating that its employees pay for this furlough with paid vacation time, Business Insider reports, citing several sources. Some Oracle employees have been angered about this move that basically removes four days of paid time off from them, the report says. Reference Link
September 29, 2015
11:10 EDTCLXClorox to host analyst meeting
Analyst meeting to be held in New York on October 1 at 9 am. Webcast Link
08:39 EDTORCLOracle Health Sciences adds 93 biopharma customers
Oracle (ORCL) Health Sciences announced that 93 emerging biopharma organizations worldwide have become new customers in the past year, adopting Oracle Health Sciences solutions to succeed in this rapidly evolving market and deliver drugs to patients faster. Organizations, including Accera and NewLink (NLNK), selected Oracle Health Sciences solutions to manage their end-to-end clinical trial processes, boost clinical development productivity, facilitate compliance, and build scalable, affordable platforms for growth.
08:39 EDTRMTIRockwell Medical weakness creates buying opportunity, says Oppenheimer
Subscribe for More Information
September 28, 2015
06:32 EDTHLFHerbalife volatility flat on tight price movement
Subscribe for More Information
06:28 EDTHLFHerbalife volatility flat on tight price movement
Subscribe for More Information
September 25, 2015
06:39 EDTHUMAPA: Big insurance firm mergers could harm mental healthcare, Reuters says
Subscribe for More Information
05:08 EDTHLFStocks with implied volatility movement; PFE HLF
Subscribe for More Information
September 24, 2015
16:23 EDTRCLRoyal Caribbean files to end secondary listing on Oslo Exchange
Subscribe for More Information
September 23, 2015
10:20 EDTORCLOptions with decreasing implied volatility
Options with decreasing implied volatility: CVC HRTX NWBO ATML RHT KMX OVTI ADBE ORCL DRI
08:11 EDTHUMLeerink sees less political risk for Managed Care mergers after hearings
Subscribe for More Information
September 22, 2015
20:02 EDTHUMClinton vows $250 cap on monthly drug costs in blast against biotechs, insurers
Democratic presidential candidate Hillary Clinton railed against biotech companies as well as health insurers at a community health care forum in Iowa on Tuesday. Clinton began her speech by praising the Affordable Care Act, but quickly noted that she wants to strengthen it due to what she called the rising cost of prescription drugs. She explained, "Our pharmaceutical and biotechnology industries deserve credit... [But] too often, these drugs cost a fortune. Now, sometimes there is a good reason for that. Scientific breakthroughs are often the result of major investment... so it may makes sense, for a short period of time, to have to charge a lot of money for a drug. But when a drug has no competition, when there aren't any other treatments that can do what it does, pharmaceutical companies can charge astronomical fees far beyond anything that it would take to recoup their investment, and far beyond what they charge consumers anywhere else in the world outside of America." Referencing the recent criticism against Turing Pharmaceuticals, Clinton went on to say that "pharmaceutical companies that acquire an existing affordable drug that people rely on, and then turn around and charge a fortune for it, [are just betting] on the fact that desperate people will find some way to pay for it." Preemptively responding to questions of whether greater regulation will dampen investment, Clinton commented that "some people worry that my proposals will threaten innovation, but I have designed a plan that will do exactly the opposite... Under my plan, drug companies that want to keep getting federal support will have to redirect more of their profits into meaningful investments in research and development." Clinton also criticized incremental drug improvements, saying that "too often, so-called new drugs are really old drugs that have just been tweaked a little bit, but then they're marketed as breakthrough drugs and they're sold for high prices." The Democratic candidate went on to condemn advertising in the drug industry, remarking that "I also want to tackle direct to consumer advertising... Other countries ban these ads because they are so often misleading. But at the very least, we shouldn't be encouraging them with corporate write-offs... Under my plan, we will instead use that taxpayer money to fund innovation... I would also like to make sure any ads the drug industry does run are approved by the FDA." Moving more broadly onto Medicaid and health insurers, Clinton stated, "I believe Medicare should be able to negotiate for lower prices for its members... I will require drug companies to provide higher rebates for prescription drugs to low income Medicare patients, just like they have to do for Medicaid patients... I think the insurance companies need to be put on notice." Providing more concrete details of her plan, Clinton concluded, "I will cap out of pocket drug costs for working families. You won't have to pay more than $250 a month for covered medications... Particularly for people who have a chronic illness. Also under my plan, you will be able to import cheaper drugs from other countries legally. If the medicine you need costs less in Canada, you should be able to buy it from Canada or any other country that meets our safety standards... I will also make sure we have more generics on the market [by boosting funding for] the FDA's office of generic drugs."
14:52 EDTHUMAetna plans to raise Humana wages after merger, Bloomberg says
Aetna (AET) CEO Mark Bertolini plans to raise wages to $16 per hour for about 10,000 low-wage Humana (HUM) employees if the prospective merger of the two companies goes through, reports Bloomberg, citing written testimony at a U.S. Senate subcommittee hearing. "Our hope is these initiatives will help reduce employee turnover," explained Bertolini. Reference Link
11:39 EDTRCLCarnival sinks after quarterly profit outlook misses expectations
Shares of cruise line operator Carnival Corp (CCL, CUK) are lower in morning trading after the company reported third quarter GAAP earnings per share and revenue that declined from a year ago and its earnings outlook for the fourth quarter fell short of expectations. WHAT'S NEW: Carnival reported Q3 EPS, including unrealized losses on fuel derivatives of $137M, of $1.56 per share, down slightly from the year-ago period and below analysts' consensus estimates of $1.63; excluding items, EPS for the quarter was $1.75. Revenue for Q3 was $4.88B, below $4.95B a year ago, but above analysts' consensus estimate of $4.82B. Net revenue yields in the quarter increased 4.3% on a constant dollar basis, above the June guidance of a 2%-3% increase, while gross revenue yields fell 2.1% in current dollars. Carnival also said that net cruise costs excluding fuel per available lower berth day, or ALBD, were up 1% in constant dollars, better than the guidance of 2%-3%, and fuel prices fell 33% to $439 per metric ton from $650 per metric ton last year. Looking ahead, Carnival raised its fiscal year 2015 adjusted EPS view to $2.56-$2.60 from $2.35-$2.50, against a consensus estimate of $2.55, and raised its FY15 revenue yield view to 4% from 3%-4%. The guidance was raised based on the strength in Q3 net revenue yields and current booking trends, the company said. The company still expects FY15 net cruise costs excluding fuel per ALBD to up about 3.5% from the prior year on a constant currency basis. Fourth quarter adjusted EPS is seen at 36c-40c, below analysts' consensus estimate of 46c, with net revenue yields expected to increase approximately 3% from the prior year. Carnival said net cruise costs excluding fuel per ALBD for Q4 are expected to be higher by approximately 3% on a constant currency basis compared to the prior year. WHAT'S NOTABLE: Carnival President and Chief Executive Officer Arnold Donald commented in the earnings release that the company is "accelerating progress" toward achieving a double digit return on invested capital over the next three to four years, adding that operating cash is expected to exceed $4B this year. Donald also noted that cumulative advance bookings for the first half of 2016 are "well ahead" of last year at lower constant dollar prices. Looking to 2016, Donald said "we have driven a significant lengthening of the booking curve and have less inventory remaining for the first half of 2016 than at this time last year, which bodes well for continued year-over-year revenue yield improvement." On the company's earnings conference call, Carnival said its cash position is "unchanged" following construction delays and said China is still a source of "aggressive" growth. Carnival said it is on track for a 2% reduction in fuel consumption this year. PRICE ACTION: Carnival Corp. shares are down 5.5% to $49.80 in late morning trading. OTHERS TO WATCH: Carnival peer Royal Caribbean Cruises (RCL) is down 4.5% to $92.79, and another peer, Norwegian Cruise Line Holdings (NCLH), is down 3.5% to $60.14. Royal Caribbean and Norwegian are expected to report quarterly results in October.
08:37 EDTHUMAetna, Anthem CEOs set to testify to Senate committee, WSJ reports
Subscribe for More Information
08:04 EDTRCLCitrix says Royal Caribbean deploys mobile workspace solution
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use